SHB/CALL/ASTRAZENECA/1850/0.05/20.06.24 Stock

Warrant

AZN4F1850SHB

SE0020827095

Market Closed - Nasdaq Stockholm 07:15:32 2024-02-16 am EST
0.27 ^SEK	+22.73%

Current year

-78.40%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ASTRAZENECA PLC

Chart SHB/CALL/ASTRAZENECA/1850/0.05/20.06.24

Static data

Product type	Warrants
Buy / Sell	CALL
Underlying	ASTRAZENECA PLC
Issuer	Svenska Handelsbanken
	AZN4F1850SHB
ISIN	SE0020827095
Date issued	2023-09-14
Strike	1,850 kr
Maturity	2024-06-20 (20 Days)
Parity	20 : 1
Emission price	- kr
Emission volume	N/A
Settlement	règlement en espèces
Currency	SEK

Technical Indicators

Highest since issue	1.29 kr
Lowest since issue	0.17 kr
Delta	0.03x
Omega	41.74
Premium	12.68x
Gearing	1263.85x
Moneyness	0.8881
Difference Strike	207 kr
Difference Strike %	+11.19%
Spread	0.01 kr
Spread %	14.29%
Theoretical value	0.0650
Implied Volatility	26.66 %
Total Loss Probability	97.13 %
Intrinsic value	0.000000
Present value	0.0650
Break even	1,851.30 kr
Theta	-0.07x
Vega	0.01x
Rho	0x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

More about the company